aluates Reports

$ 0.0

Automative

Global Vesicular Stomatitis (VS) Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-21J14132

Global Vesicular Stomatitis VS Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Vesicular Stomatitis (VS) Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-21J14132

Report

December 2024

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Boehringer Ingelheim

Merck

Zoetis Inc

Vedco

Elanco

Ceva Santé Animale

Vibrac

Vetoquinol

IDEXX Laboratories

Covetrus

Neogen

Grand Pharmaceutical Group

Vesicular Stomatitis (VS) Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Vesicular Stomatitis (VS) Therapeutics Market

Vesicular stomatitis is a zoonotic viral disease that primarily affects equines, cattle and swine. The virus can also infect sheep and goats as well as wildlife.

Market Analysis and Insights: Global Vesicular Stomatitis (VS) Therapeutics Market

The global Vesicular Stomatitis (VS) Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Vesicular Stomatitis (VS) Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Vesicular Stomatitis (VS) Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Vesicular Stomatitis (VS) Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vesicular Stomatitis (VS) Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Vesicular Stomatitis (VS) Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Vesicular Stomatitis (VS) Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Vesicular Stomatitis (VS) Therapeutics Market Report

Report Metric	Details
Report Name	Vesicular Stomatitis (VS) Therapeutics Market
CAGR	5%
Segment by Type	Symptomatic Medications Vaccination
Segment by Application	Veterinary Hospitals Veterinary Clinics Retail Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boehringer Ingelheim, Merck & Co, Zoetis, Vedco, Elanco, Ceva Santé Animale, Vibrac, Vetoquinol, IDEXX Laboratories, Covetrus, Neogen, Grand Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Vesicular Stomatitis (VS) Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vesicular Stomatitis (VS) Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vesicular Stomatitis (VS) Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Vesicular Stomatitis (VS) Therapeutics Market report?

Ans: The main players in the Vesicular Stomatitis (VS) Therapeutics Market are Boehringer Ingelheim, Merck & Co, Zoetis, Vedco, Elanco, Ceva Santé Animale, Vibrac, Vetoquinol, IDEXX Laboratories, Covetrus, Neogen, Grand Pharmaceutical Group

What are the Application segmentation covered in the Vesicular Stomatitis (VS) Therapeutics Market report?

Ans: The Applications covered in the Vesicular Stomatitis (VS) Therapeutics Market report are Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies

What are the Type segmentation covered in the Vesicular Stomatitis (VS) Therapeutics Market report?

Ans: The Types covered in the Vesicular Stomatitis (VS) Therapeutics Market report are Symptomatic Medications, Vaccination

Recommended Reports

Viral Disease Therapeutics

Veterinary & Livestock Health

Mucosal & Soft Tissue Conditions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Symptomatic Medications

1.2.3 Vaccination

1.3 Market by Application

1.3.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Veterinary Hospitals

1.3.3 Veterinary Clinics

1.3.4 Retail Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Perspective (2019-2030)

2.2 Global Vesicular Stomatitis (VS) Therapeutics Growth Trends by Region

2.2.1 Vesicular Stomatitis (VS) Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Vesicular Stomatitis (VS) Therapeutics Market Dynamics

2.3.1 Vesicular Stomatitis (VS) Therapeutics Industry Trends

2.3.2 Vesicular Stomatitis (VS) Therapeutics Market Drivers

2.3.3 Vesicular Stomatitis (VS) Therapeutics Market Challenges

2.3.4 Vesicular Stomatitis (VS) Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Vesicular Stomatitis (VS) Therapeutics by Players

3.1.1 Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Vesicular Stomatitis (VS) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio

3.4.1 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Vesicular Stomatitis (VS) Therapeutics Revenue in 2023

3.5 Global Key Players of Vesicular Stomatitis (VS) Therapeutics Head office and Area Served

3.6 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application

3.7 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Type

4.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2025-2030)

5 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Application

5.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size (2019-2030)

6.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type

6.2.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

6.3 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application

6.3.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

6.4 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country

6.4.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size (2019-2030)

7.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type

7.2.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

7.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application

7.3.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

7.4 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country

7.4.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Vesicular Stomatitis (VS) Therapeutics Market Size (2019-2030)

8.2 China Vesicular Stomatitis (VS) Therapeutics Market Size by Type

8.2.1 China Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024)

8.2.2 China Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030)

8.2.3 China Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

8.3 China Vesicular Stomatitis (VS) Therapeutics Market Size by Application

8.3.1 China Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024)

8.3.2 China Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030)

8.3.3 China Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Vesicular Stomatitis (VS) Therapeutics Market Size (2019-2030)

9.2 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type

9.2.1 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

9.3 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application

9.3.1 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

9.4 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region

9.4.1 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Boehringer Ingelheim

11.1.1 Boehringer Ingelheim Company Details

11.1.2 Boehringer Ingelheim Business Overview

11.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Introduction

11.1.4 Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.1.5 Boehringer Ingelheim Recent Developments

11.2 Merck & Co

11.2.1 Merck & Co Company Details

11.2.2 Merck & Co Business Overview

11.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Introduction

11.2.4 Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.2.5 Merck & Co Recent Developments

11.3 Zoetis

11.3.1 Zoetis Company Details

11.3.2 Zoetis Business Overview

11.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Introduction

11.3.4 Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.3.5 Zoetis Recent Developments

11.4 Vedco

11.4.1 Vedco Company Details

11.4.2 Vedco Business Overview

11.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Introduction

11.4.4 Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.4.5 Vedco Recent Developments

11.5 Elanco

11.5.1 Elanco Company Details

11.5.2 Elanco Business Overview

11.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Introduction

11.5.4 Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.5.5 Elanco Recent Developments

11.6 Ceva Santé Animale

11.6.1 Ceva Santé Animale Company Details

11.6.2 Ceva Santé Animale Business Overview

11.6.3 Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Introduction

11.6.4 Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.6.5 Ceva Santé Animale Recent Developments

11.7 Vibrac

11.7.1 Vibrac Company Details

11.7.2 Vibrac Business Overview

11.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Introduction

11.7.4 Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.7.5 Vibrac Recent Developments

11.8 Vetoquinol

11.8.1 Vetoquinol Company Details

11.8.2 Vetoquinol Business Overview

11.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Introduction

11.8.4 Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.8.5 Vetoquinol Recent Developments

11.9 IDEXX Laboratories

11.9.1 IDEXX Laboratories Company Details

11.9.2 IDEXX Laboratories Business Overview

11.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Introduction

11.9.4 IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.9.5 IDEXX Laboratories Recent Developments

11.10 Covetrus

11.10.1 Covetrus Company Details

11.10.2 Covetrus Business Overview

11.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Introduction

11.10.4 Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.10.5 Covetrus Recent Developments

11.11 Neogen

11.11.1 Neogen Company Details

11.11.2 Neogen Business Overview

11.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Introduction

11.11.4 Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.11.5 Neogen Recent Developments

11.12 Grand Pharmaceutical Group

11.12.1 Grand Pharmaceutical Group Company Details

11.12.2 Grand Pharmaceutical Group Business Overview

11.12.3 Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Introduction

11.12.4 Grand Pharmaceutical Group Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

11.12.5 Grand Pharmaceutical Group Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Boehringer Ingelheim

Merck

Zoetis Inc

Vedco

Elanco

Ceva Santé Animale

Vibrac

Vetoquinol

IDEXX Laboratories

Covetrus

Neogen

Grand Pharmaceutical Group

List of Tables

Table 1. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Symptomatic Medications

Table 3. Key Players of Vaccination

Table 4. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2019-2024)

Table 8. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2025-2030)

Table 10. Vesicular Stomatitis (VS) Therapeutics Market Trends

Table 11. Vesicular Stomatitis (VS) Therapeutics Market Drivers

Table 12. Vesicular Stomatitis (VS) Therapeutics Market Challenges

Table 13. Vesicular Stomatitis (VS) Therapeutics Market Restraints

Table 14. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Vesicular Stomatitis (VS) Therapeutics Revenue Share by Players (2019-2024)

Table 16. Global Top Vesicular Stomatitis (VS) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2023)

Table 17. Global Vesicular Stomatitis (VS) Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application

Table 21. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Vesicular Stomatitis (VS) Therapeutics Revenue Share by Application (2019-2024)

Table 29. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Vesicular Stomatitis (VS) Therapeutics Revenue Share by Application (2025-2030)

Table 31. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Vesicular Stomatitis (VS) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Vesicular Stomatitis (VS) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Vesicular Stomatitis (VS) Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 63. Boehringer Ingelheim Company Details

Table 64. Boehringer Ingelheim Business Overview

Table 65. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product

Table 66. Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 67. Boehringer Ingelheim Recent Developments

Table 68. Merck & Co Company Details

Table 69. Merck & Co Business Overview

Table 70. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product

Table 71. Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 72. Merck & Co Recent Developments

Table 73. Zoetis Company Details

Table 74. Zoetis Business Overview

Table 75. Zoetis Vesicular Stomatitis (VS) Therapeutics Product

Table 76. Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 77. Zoetis Recent Developments

Table 78. Vedco Company Details

Table 79. Vedco Business Overview

Table 80. Vedco Vesicular Stomatitis (VS) Therapeutics Product

Table 81. Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 82. Vedco Recent Developments

Table 83. Elanco Company Details

Table 84. Elanco Business Overview

Table 85. Elanco Vesicular Stomatitis (VS) Therapeutics Product

Table 86. Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 87. Elanco Recent Developments

Table 88. Ceva Santé Animale Company Details

Table 89. Ceva Santé Animale Business Overview

Table 90. Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Product

Table 91. Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Ceva Santé Animale Recent Developments

Table 93. Vibrac Company Details

Table 94. Vibrac Business Overview

Table 95. Vibrac Vesicular Stomatitis (VS) Therapeutics Product

Table 96. Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 97. Vibrac Recent Developments

Table 98. Vetoquinol Company Details

Table 99. Vetoquinol Business Overview

Table 100. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product

Table 101. Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 102. Vetoquinol Recent Developments

Table 103. IDEXX Laboratories Company Details

Table 104. IDEXX Laboratories Business Overview

Table 105. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product

Table 106. IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 107. IDEXX Laboratories Recent Developments

Table 108. Covetrus Company Details

Table 109. Covetrus Business Overview

Table 110. Covetrus Vesicular Stomatitis (VS) Therapeutics Product

Table 111. Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 112. Covetrus Recent Developments

Table 113. Neogen Company Details

Table 114. Neogen Business Overview

Table 115. Neogen Vesicular Stomatitis (VS) Therapeutics Product

Table 116. Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 117. Neogen Recent Developments

Table 118. Grand Pharmaceutical Group Company Details

Table 119. Grand Pharmaceutical Group Business Overview

Table 120. Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Product

Table 121. Grand Pharmaceutical Group Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024) & (US$ Million)

Table 122. Grand Pharmaceutical Group Recent Developments

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Symptomatic Medications Features

Figure 4. Vaccination Features

Figure 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Application: 2023 VS 2030

Figure 7. Veterinary Hospitals Case Studies

Figure 8. Veterinary Clinics Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Vesicular Stomatitis (VS) Therapeutics Report Years Considered

Figure 11. Global Vesicular Stomatitis (VS) Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Vesicular Stomatitis (VS) Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Players in 2023

Figure 15. Global Top Vesicular Stomatitis (VS) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue in 2023

Figure 17. North America Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

Figure 19. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

Figure 20. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Vesicular Stomatitis (VS) Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

Figure 25. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

Figure 26. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2019-2030)

Figure 27. Germany Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Vesicular Stomatitis (VS) Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

Figure 35. China Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

Figure 36. Asia Vesicular Stomatitis (VS) Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

Figure 38. Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

Figure 39. Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2019-2030)

Figure 40. Japan Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2019-2030)

Figure 50. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Boehringer Ingelheim Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 57. Merck & Co Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 58. Zoetis Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 59. Vedco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 60. Elanco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 61. Ceva Santé Animale Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 62. Vibrac Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 63. Vetoquinol Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 64. IDEXX Laboratories Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 65. Covetrus Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 66. Neogen Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 67. Grand Pharmaceutical Group Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Animal Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Xerostomia Dry Mouth Disease Therapeutics Market Insights Forecast to 2030

Global Smallpox Treatment Market Insights Forecast to 2030

Global Bacterial Vaginosis Treatment Market Insights Forecast to 2030

Global Bacterial Vaginosis Therapeutics Market Insights Forecast to 2030

Global Veterinary Infectious Diseases Therapeutics Market Insights Forecast to 2030

Global Veterinary Infectious Disease Diagnostics Market Insights Forecast to 2030

Global Poliomyelitis Therapeutics Market Insights Forecast to 2030

Global Herpes Zoster Ophthalmicus Drug Market Insights Forecast to 2030

Global Staphylococcal Infection Treatment Market Insights Forecast to 2030

Global Cattle healthcare Market Insights Forecast to 2030

Global Respiratory Syncytial Virus Treatment Market Research Report 2024

Pediatric Respiratory Syncytial Virus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Rabies Treatment Market Insights Forecast to 2030

Gingivitis Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Syncytial Virus RSV Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Equine Veterinary Therapeutics Market Research Report 2024

Global Herpes Simplex Keratitis Drug Market Insights Forecast to 2030

Global Venous Reflux Disease Treatment Market Research Report 2025

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions